HopeStage
Back to all studies
Active Not RecruitingNCT04931134

Trigeminal nerve stimulation for anxiety conditions

About this titleRead the official source — NCT04931134
Device studyAges 18–65Canada
The study in practice

Understand this study

Who could participate?

This study is for people with anxiety. Listed age limits: 18 years to 65 years. Other eligibility criteria apply.

Listed locations
KingstonSee all locations and recruitment

Get this study by email

HopeStage may email me about this study.
Loading the security check...

What to know before participating

A point to clarify

This summary does not cover all risks or eligibility requirements. What risks or changes to my care would apply to me?

Study clarity

Things to check before joining

Study start dateStarted: February 7, 2022
Recruitment status
Active Not Recruiting
Enrollment listed in the registry
1
Sponsor
Dr. Rafael Freire
Sponsor type
Individual investigator
Study type
Device
Intervention type
Device
Locations
Canada
Age range
From 18 Years to 65 Years
Official registry ID
NCT04931134
Official title
Show the full official title

Trigeminal Nerve Stimulation in Anxiety Disorders: a Randomized Controlled Trial

Recruitment & locations

Not recruiting

Kingston

Interested in joining this study?

HopeStage may email me about this study.
Loading the security check...
FAQ

Questions about this study

Who is behind this study?

The study sponsor is Dr. Rafael Freire.

Who can participate?

This study is for people with anxiety. Listed age limits: 18 years to 65 years. Other eligibility criteria apply.

Is this study still recruiting?

The registry lists this study as active, but no longer recruiting.

Want to explore more studies?

Explore studies